Clinical Decision Making in Wound Dressing Selection

Effective wound dressing selection requires integration of wound assessment data, patient-specific factors, and economic considerations within a structured clinical decision framework. The Wound Bed Preparation paradigm (TIME framework: Tissue management, Infection/Inflammation control, Moisture balance, Edge advancement), endorsed by the World Union of Wound Healing Societies (WUWHS), provides the conceptual model for dressing selection. A 2020 international consensus document from WUWHS emphasizes that dressing choice should be reassessed at each dressing change based on evolving wound characteristics — no single dressing is appropriate throughout the entire healing trajectory.

The TIME Clinical Decision Framework

T — Tissue Management

Assessment: Evaluate wound bed tissue type — necrotic (black/brown eschar), sloughy (yellow/tan non-viable tissue), granulating (red/pink healthy tissue), or epithelializing (pink/white new skin).

Dressing Selection:

• Necrotic/eschar → Hydrogel dressings (autolytic debridement) or enzymatic debridement agents. Sharp debridement first if clinically appropriate and within scope of practice.
• Sloughy → Hydrogel, hydrocolloid, or alginate dressings. Promote autolytic debridement through moisture donation.
• Granulating → Moisture-retentive non-adherent dressing appropriate to exudate level (foam, hydrocolloid, alginate). Protect fragile granulation tissue from trauma during dressing changes.
• Epithelializing → Low-adherent, protective dressing (thin hydrocolloid, film, non-adherent). Minimize dressing changes — epithelial cells are easily disrupted.

I — Infection / Inflammation Control

Assessment: Clinical signs of infection: erythema, edema, increased exudate/purulence, odor, pain, delayed healing despite optimal care. Wound culture (Levine quantitative swab technique or tissue biopsy) if infection suspected. NERDS (Non-healing, Exudate, Red/bleeding tissue, Debris, Smell) and STONEES (Size increasing, Temperature elevation, Osseous exposure, New breakdown, Erythema/edema, Exudate, Smell) mnemonics for superficial and deep wound infection assessment.

Dressing Selection:

• Superficial infection (NERDS positive) → Topical antimicrobial dressing (silver, iodine, PHMB, honey). Monitor for clinical improvement within 2 weeks — if no response, reassess and consider systemic antibiotics.
• Deep infection (STONEES positive) → Systemic antibiotics per culture sensitivities + antimicrobial dressing topically. Surgical debridement may be required.
• Biofilm management → Serial sharp debridement + antimicrobial dressing. Biofilm re-forms within 24 hours — dressing change frequency of 24-72 hours recommended during active biofilm management.
• No infection, normal inflammation → Non-antimicrobial dressing appropriate to exudate level. Prophylactic antimicrobial dressings not recommended — no evidence of benefit, risk of resistance, and added cost.

M — Moisture Balance

Assessment: Quantify exudate: none/dry, low (dressing minimally stained), moderate (dressing saturated but no leakage), high (dressing saturated with leakage/strike-through), very high (requires frequent changes, periwound maceration present).

Dressing Selection:

• Dry → Hydrogel (donates moisture). Secondary non-adherent cover.
• Low exudate → Hydrocolloid, thin foam, film dressing. Change every 3-7 days.
• Moderate exudate → Foam dressing (sheet or bordered), alginate + foam secondary. Change every 2-5 days.
• High exudate → Alginate/Hydrofiber primary + foam/super-absorbent secondary. Consider negative pressure wound therapy (NPWT) for very high output. Change frequency driven by strike-through (primary dressing) or saturation (secondary dressing).
• Very high exudate → NPWT consultation, ostomy appliance for fistula management, super-absorbent polymer dressings. Daily or multiple daily changes.

E — Edge Advancement

Assessment: Wound edge characteristics: rolled/undermined edges, hyperkeratotic/callused edges, macerated edges. Measure wound dimensions at each assessment to track healing trajectory.

Dressing Selection: If wound not reducing in size (20-30% reduction at 4 weeks is standard healing expectation for chronic wounds), reassess all TIME parameters. Consider: inadequate debridement, subclinical infection/biofilm, moisture imbalance, underlying pathology (venous insufficiency, arterial disease, uncontrolled diabetes, malnutrition, pressure). Dressing selection alone may be insufficient — address underlying etiology.

Patient-Centered Considerations

Effective wound care requires balancing clinical efficacy with patient-specific factors: (1) Pain — atraumatic dressings (silicone, hydrogel) for painful wounds. Pre-medicate if necessary before dressing changes. (2) Lifestyle — waterproof dressings for bathing/swimming. Low-profile dressings under clothing. (3) Self-care capability — bordered dressings for self-application. Consider patient/caregiver education on dressing change technique. (4) Cost and access — consider product availability in community/outpatient settings. (5) Adherence — once-daily or extended-wear dressings improve adherence compared to multiple daily changes.

Economic Considerations

Dressing cost should be evaluated in the context of total episode cost: product cost + nursing time (primary driver — dressing change frequency), secondary products (tape, skin barrier, adhesive remover), complication management costs (infection, maceration), and healing time (longer healing = more dressing changes). Extended-wear dressings (foam, hydrocolloid — 3-7 day change interval) may appear more expensive per unit but often demonstrate superior cost-effectiveness compared to daily-change dressings (gauze, non-adherent) when nursing time is included in the analysis. Linmed Medical clinical support team provides health economic analysis resources to support formulary decision-making.